Your browser doesn't support javascript.
loading
Efficacy of Trametinib in Neurofibromatosis Type 1-Associated Gastrointestinal Stromal Tumors: A Case Report.
Fukuda, Misao; Mukohara, Toru; Kuwata, Takeshi; Sunami, Kuniko; Naito, Yoichi.
Affiliation
  • Fukuda M; Department of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Mukohara T; Department of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Kuwata T; Department of Genetic Medicine and Services, National Cancer Center Hospital East, Kashiwa, Japan.
  • Sunami K; Department of Genetic Medicine and Services, National Cancer Center Hospital East, Kashiwa, Japan.
  • Naito Y; Department of Laboratory Medicine, National Cancer Center Hospital, Tokyo, Japan.
JCO Precis Oncol ; 8: e2300649, 2024 Aug.
Article in En | MEDLINE | ID: mdl-39116355
ABSTRACT
Trametinib, an MEK inhibitor, may offer a new therapeutic option for patients with NF1-related GIST.
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridones / Pyrimidinones / Neurofibromatosis 1 / Gastrointestinal Stromal Tumors Limits: Female / Humans / Male / Middle aged Language: En Journal: JCO Precis Oncol Year: 2024 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridones / Pyrimidinones / Neurofibromatosis 1 / Gastrointestinal Stromal Tumors Limits: Female / Humans / Male / Middle aged Language: En Journal: JCO Precis Oncol Year: 2024 Document type: Article Affiliation country: